American College of Chest Physicians (CHEST) Global leader in clinical chest medicine. #CHEST2026 #JournalCHEST
The American College of Chest Physicians (CHEST) is the leading professional association in innovative chest medicine. We advance the best health outcomes for patients with lung disease through education, advocacy, research, and philanthropy. CHEST is the professional home for more than 18,000 pulmonary, critical care, and sleep medicine professionals seeking clinical education and connection to t
he worldwide chest medicine community. CHEST's innovative education options include live learning, online learning, and self-study products. Our Innovation, Simulation, and Training Center, located at CHEST headquarters in Glenview, Illinois, includes an auditorium, simulation rooms, breakout rooms, and a wet and dry laboratory for hands-on learning that helps put the latest clinical advances into immediate practice. CHEST is the first medical society ever to receive accreditation from the Society for Simulation in Healthcare and holds Accreditation With Commendation from the Accreditation Council for Continuing Medical Education. CHEST courses include critical care ultrasonography, bronchoscopy, airway management, mechanical ventilation, and critical care management. The CHEST Annual Meeting offers 5 days of clinical instruction with hundreds of sessions focusing on relevant pulmonary, critical care, and sleep medicine topics. To learn more about the annual meeting, visit: https://chestmeeting.chestnet.org/
Please note: CHEST reserves the right to remove any post and block any user that promotes medical misinformation or engages in vulgar, biased, prejudicial speech or makes defamatory statements based on, but not limited to, an individual's race, age, religion, creed, color, ancestry, citizenship, national or ethnic origin, language, immigration status, disability, medical condition, military, or veteran status, social or socioeconomic status or condition, sex, gender identity or expression, or sexual orientation.
06/14/2026
Stephanie Lee, PharmD, and Isabel A. Mangaoang, PharmD, join CHEST® Critical Care Podcast Moderator Gretchen Sacha, PharmD, BCCCP, FCCM, to discuss their research into the sedation gap that can occur in patients who are critically ill and undergoing bedside procedural paralysis.
Nominations due tomorrow at 2PM CT! Attend an exclusive course ahead of and explore topics such as advanced airway rescue, bronchoscopic control of bleeding, extracorporeal support for respiratory failure, and more. Submit a nomination today: https://hubs.la/Q04j2VCJ0
06/14/2026
Physical and Psychological Outcomes of Intensive Care Survivors Comparing Patients Who Received Venovenous Extracorporeal Membrane Oxygenation With Those Receiving Conventional Ventilation for a Minimum of 3 Days: A Cohort Study
A How I Do It article defines key terminology, articulates the rationale for discussing harm, and offers a compassionate, evidence-based framework to hold the initial conversation with patients and families affected by harm in the ICU.
A research letter sought to assess the frequency and content of goals of care conversation notes documented in the electronic health record for patients experiencing delirium in the ICU.
We're thrilled to recognize the latest CHEST Critical Care Advanced Practice Provider (CCAPP) certificants. Join us in congratulating Bobbie Jackson, MSN, APRN, AGACNP-BC, CCAPP, on earning this distinguished credential!
Applications for Fall 2026 are now open. The exam can be taken online between October 27 and November 13, 2026. Learn more: https://hubs.la/Q04lfpWR0
06/12/2026
A How I Do It article presents three patient scenarios to illustrate the management of anemia in hemodynamically stable critically ill patients.
A CHEST Research Letter presents a case series of nine patients treated off label with sotatercept for precapillary pulmonary hypertension associated with sarcoidosis and the unexpected improvement in lung function demonstrated.
Will an externally validated machine learning model predict BiPAP failure with greater discrimination compared with the existing HACOR score and ROX index?